Erratum: MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4 (Journal of Clinical Investigation (2015) 125:2 (699-714) DOI:10.1172/JCI76210);MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4

Journal of Clinical Investigation

Volumn 125, Issue 2, 2015, Pages 699-714

  Walsh, James T ^a   Hendrix, Sven ^b,c   Boato, Francesco ^c,d   Smirnov, Igor ^a   Zheng, Jingjing ^a,e   Lukens, John R ^a,f   Gadani, Sachin ^a   Hechler, Daniel ^c   Gölz, Greta ^c   Rosenberger, Karen ^c   Kammertöns, Thomas ^g   Vogt, Johannes ^c,d   Vogelaar, Christina ^d   Siffrin, Volker ^h   Radjavi, Ali ^a   Fernandez Castaneda, Anthony ^a   Gaultier, Alban ^a   Gold, Ralf ⁱ   Kanneganti, Thirumala Devi ^f   Nitsch, Robert ^c,d   Zipp, Frauke ^h   Kipnis, Jonathan ^a   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b HASSELT UNIVERSITY   (Belgium)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^h JOHANNES GUTENBERG UNIVERSITY   (Germany)

ⁱ ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NEUROTROPHIN; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; HLA ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR; MYD88 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM INJURY; CONTROLLED STUDY; DISEASE ASSOCIATION; MOLECULAR INTERACTION; MOUSE; MURINE MODEL; NERVE CELL; NERVE CELL CULTURE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; BRAIN INJURY; DEGENERATIVE DISEASE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; NERVE FIBER; PATHOLOGY;

ANIMALS; AXONS; BRAIN INJURIES; CD4-POSITIVE T-LYMPHOCYTES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-4; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NEURODEGENERATIVE DISEASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL;

EID: 84922148661     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI82458     Document Type: Erratum

References (45)

1. Yoles E, Schwartz M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol. 1998;153(1):1-7.
2. Bettelli E, Baeten D, Jäger A, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest. 2006;116(9):2393-2402.
3. Luger D, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008;205(4):799-810.
4. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. Differential regulation of central nervous system autoimmunity by T (H) 1 and T (H) 17 cells. Nat Med. 2008;14(3):337-342.
5. Cayrol R, et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol. 2008;9(2):137-145.
6. Krishnamoorthy G, et al. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med. 2009;15(6):626-632.
7. Dunn SE, et al. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J Exp Med. 2010;207(8):1599-1608.
8. Popovich PG, Stokes BT, Whitacre CC. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res. 1996;45(4):349-363.
9. Fee D, et al. Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. J Neuroimmunol. 2003;136(1-2):54-66.
10. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med. 1999;5(1):49-55.
11. Hauben E, et al. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci. 2000;20(17):6421-6430.
12. Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, Weiner HL. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci. 2005;233(1-2):125-132.
13. Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M. Neuroprotective autoimmunity: Naturally occurring CD4 (+) CD25 (+) regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci U S A. 2002;99(24):15620-15625.
14. Jones TB, et al. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci. 2004;24(15):3752-3761.
15. Archambault AS, Sim J, Gimenez MA, Russell JH. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur J Immunol. 2005;35(4):1076-1085.
16. Tikhonova AN, et al. αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity. 2012;36(1):79-91.
17. Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci. 2001;21(13):4564-4571.
18. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal. J Neurotrauma. 2006;23(5):635-659.
19. Takeda S, Rodewald HR, Arakawa H, Bluethmann H, Shimizu T. MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity. 1996;5(3):217-228.
20. Nesic D, Vukmanovic S. MHC class I is required for peripheral accumulation of CD8+ thymic emigrants. J Immunol. 1998;160(8):3705-3712.
21. Derecki NC, et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010;207(5):1067-1080.
22. Baruch K, et al. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc Natl Acad Sci U S A. 2013;110(6):2264-2269.
23. Blaeser F, et al. Targeted inactivation of the IL-4 receptor alpha chain I4R motif promotes allergic airway inflammation. J Exp Med. 2003;198(8):1189-1200.
24. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci. 2006;361(1473):1545-1564.
25. Falcone M, Bloom BR. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med. 1997;185(5):901-907.
26. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997;89(4):587-596.
27. Mohrs K, Wakil AE, Killeen N, Locksley RM, Mohrs M. A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity. 2005;23(4):419-429.
28. Oppenheim JJ, Tewary P, De La Rosa G, Yang D. Alarmins initiate host defense. Adv Exp Med Biol. 2007;601:185-194.
29. Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity. 2004;21(5):733-741.
30. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 1999;11(1):115-122.
31. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39(6):1003-1018.
32. Woodhams PL, Atkinson DJ. Regeneration of entorhino-dentate projections in organotypic slice cultures: mode of axonal regrowth and effects of growth factors. Exp Neurol. 1996;140(1):68-78.
33. Hechler D, Boato F, Nitsch R, Hendrix S. Differential regulation of axon outgrowth and reinnervation by neurotrophin-3 and neurotrophin-4 in the hippocampal formation. Exp Brain Res. 2010;205(2):215-221.
34. Prang P, Del Turco D, Kapfhammer JP. Regeneration of entorhinal fibers in mouse slice cultures is age dependent and can be stimulated by NT-4, GDNF, and modulators of G-proteins and protein kinase C. Exp Neurol. 2001;169(1):135-147.
35. Sun XJ, et al. Role of IRS-2 in insulin and cytokine signalling. Nature. 1995;377(6545):173-177.
36. Zweifel LS, Kuruvilla R, Ginty DD. Functions and mechanisms of retrograde neurotrophin signalling. Nat Rev Neurosci. 2005;6(8):615-625.
37. Flugel A, et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity. 2001;14(5):547-560.
38. Hendrix S, Nitsch R. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol. 2007;184(1-2):100-112.
39. Bennett MH, Trytko B, Jonker B. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury. Cochrane Database Syst Rev. 2012;12: CD004609.
40. Ma J, Huang S, Qin S, You C. Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev. 2012;10: CD008409.
41. Sydenham E, Roberts I, Alderson P. Hypothermia for traumatic head injury. Cochrane Database Syst Rev. 2009;2(2): CD001048.
42. Boato F, et al. Absence of IL-1β positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury. J Neuroinflammation. 2013;10:6.
43. Buch T, et al. MHC class II expression through a hitherto unknown pathway supports T helper cell-dependent immune responses: implications for MHC class II deficiency. Blood. 2006;107(4):1434-1444.
44. Slaets H, et al. Oncostatin m reduces lesion size and promotes functional recovery and neurite outgrowth after spinal cord injury. Mol Neurobiol. 2014;50(3):1142-1151.
45. Boato F, et al. Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro. J Neuroinflammation. 2011;8:183.